Skip to main content

Contact Yi Ba

From: The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer

Contact corresponding author

Cancer Communications

ISSN: 2523-3548

Contact us